The CDER is the center in the FDA responsible for the following:

• Acceptance and review of an investigational new drug application (INDA) prior to initiating a clinical trial;



• Inspection of manufacturers and clinical trial participants (e.g. investigator site);



• Review and issuance of drug approval;



• Post-marketing surveillance of approved drugs.